Abstract:Objective To investigate the oxidative stress damage and mechanism of osthole (Ost)on panc-1 cells,and to provide experimental evidence for the treatment of pancreatic cancer with Chinese medicine.Methods Panc-1 cells were treated with different concentrations of Ost,and the proliferation of cells was detected by Alamar blue method.The cell viability was detected by trypan blue counting method.The cellular reactive oxygen species (ROS) content and cell cycle were detected by flow cytometry.The expression of Cyclin D1,Cyclin D3 and Notch1 in panc-1 cells was detected by Western blotting.The statistical method used one-way analysis of variance.Results The proliferation activity of panc-1 cells decreased under the action of Ost,and the concentration-dependent,drug inhibition rates of 10,20,40,80,120,160,200 μmol/Lwere (0.095 ±0.056)％,(0.164±0.033)％ (0.201± 0.034)％,(0.267 ± 0.037) ％,(0.537 ± 0.028) ％,(0.732 ± 0.015) ％,(0.936 ± 0.002) ％.Flow cytometry results showed that ROS increased with increasing concentration and could be effectively reversed by antioxidant (NAC).The ROS value was 0 μmol/L:17.700 ±0.795,80 μmol/L:19.750 ±0.101,NAC +80 μmol/L:17.850±0.236.Trypan blue count showed a decrease in cell viability,0 μmol/L:100.000± 7.536,80 μmol/L:65.610 ±4.351,NAC + 80 μmol/L:76.110 ± 1.603.After 48 h of Ost effect,G0/G1 phase increased,0 μmol/L:(57.920 ± 2.091) ％,120 μmol/L:(70.090 ± 1.558) ％;G2/M phase decreased,0 μmol/L:(26.080 ± 1.674) ％,120 μmol/L:(16.730 ± 0.781) ％.This effect was also inhibited by NAC.The G0/G1 phase of the NAC + 120 μmol/L group was (64.700 ± 2.191) ％,and the G2/M phase was (22.390 ± 1.657)％.The relative expression levels of Cyclin D1 (40 μmol/L:0.804 ±0.067,80 pμmol/L:0.462 ±0.118) and Cyclin D3 (40 μmol/L:0.845 ±0.035,80 μmol/L:0.372 ± 0.096) were also shown to decrease at the protein level.In addition,Western blotting also showed that Ost can down-regulate the relative expression of Notch1 protein (40 μmol/L:0.949 ± 0.027;80 μmol/L:0.586 ± 0.043).All results were statistically significant (P ＜ 0.05).Conclusion Ost can increase ROS in panc-1 cells in a concentration-dependent manner and inhibit proliferation by blocking cell cycle.

Osthole Suppresses Cell Growth of Prostate Cancer by Disrupting Redox Homeostasis, Mitochondrial Function, and Regulation of tiRNAHisGTG

Osthole impairs mitochondrial metabolism and the autophagic flux in colorectal cancer

In vitro anticancer activities of osthole against renal cell carcinoma cells.

Osthole Induces Apoptosis, Secondary Necrosis and Mitophagy Via NQO1-Mediated ROS Overproduction in HeLa Cells

HSP60-regulated Mitochondrial Proteostasis and Protein Translation Promote Tumor Growth of Ovarian Cancer

Hydroxytyrosol promotes superoxide production and defects in autophagy leading to anti-proliferation and apoptosis on human prostate cancer cells.

Osthole inhibits malignant phenotypes and induces ferroptosis in KRAS-mutant colorectal cancer cells via suppressing AMPK/Akt signaling

Anticancer potential of osthole: targeting gynecological tumors and breast cancer

Growth Inhibition And Apoptosis Induced By Osthole, A Natural Coumarin, In Hepatocellular Carcinoma

Osthole Inhibits the PI3K/AKT Signaling Pathway Via Activation of PTEN and Induces Cell Cycle Arrest and Apoptosis in Esophageal Squamous Cell Carcinoma.

Dihydrotanshinone I inhibits ovarian tumor growth by activating oxidative stress through Keap1-mediated Nrf2 ubiquitination degradation

Osthole induces accumulation of impaired autophagosome against pancreatic cancer cells

Potential mechanisms of osthole against bladder cancer cells based on network pharmacology, molecular docking, and experimental validation

Oridonin Induces Oxidative Stress-mediated Cancer Cells Apoptosis <i>via</i> Targeting Thioredoxin Reductase

Osthole Prevents 6-Hydroxydopamine (6-OHDA) Induced Endoplasmic Reticulum Stress and Cytotoxicity Through Activating Akt/GSK3beta Signaling Pathway in PC12 Cells

Osthole inhibits pancreatic cancer cell cycle progression and proliferation by inducing reactive oxygen species

Potential Mechanisms of Osthole against Bladder Cancer Based on Network Pharmacology, Molecular Docking, and Experimental Validation

Osthole induces G2/M cell cycle arrest and apoptosis in human hepatocellular carcinoma HepG2 cells.

Osthole Promotes Anti-Tumor Immune Responses In Tumor-Bearing Mice With Hepatocellular Carcinoma

UPLC-Q-TOF/MS-Based Metabolomics Approach Reveals Osthole Intervention in Breast Cancer 4T1 Cells

Osthole Increases the Radiosensitivity of Hepatoma Cells by Inhibiting GSK-3β/AMPK/mTOR Pathway-Controlled Glycolysis